Synapse - Pediatric Leukemia

Results (1713)

Implications of tumor characteristics and treatment modality on local recurrence and functional outcomes in children with chest wall sarcoma: A Pediatric Surgical Oncology Research Collaborative study

Journal Article

Harris, C. J.; Helenowski, I.; Murphy, A. J.; Mansfield, S. A.; LaQuaglia, M. P.; Heaton, T. E.; Cavalli, M.; Murphy, J. T.; Newman, E. A.; Overmen, R. E.; more...
Annals of Surgery (2022)

Fulltext@MSK | Save

Outcomes of MSK-NY-II therapy in pediatric and young adult patients with precursor B-cell acute lymphoblastic leukemia

Meeting Abstract

Ramaswamy, K.; Forlenza, C.; Shukla, N.; Trippett, T.; Sulis, M. L.; Steinherz, P.
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Radiation induced high grade gliomas: A single center experience

Meeting Abstract

Joshirao, M.; Sait, S. F.; Bouvier, N.; Hill, K.; Khakoo, Y.; Kramer, K.; Gilheeney, S.; Wolden, S.; Nolan, C.; Schaff, L.; more...
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis

Meeting Abstract

Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Warner, A. B.; Yu, H. A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Matching-adjusted indirect treatment comparison (MAIC) of teclistamab (tec) versus belantamab mafodotin (belamaf) for the treatment of patients (pts) with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Moreau, P.; Usmani, S. Z.; van de Donk, N. W. C. J.; Garfall, A. L.; Delforge, M.; Rocafiguera, A. O.; Nooka, A. K.; Rosiñol, L.; Bahlis, N. J.; Rodríguez-Otero, P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Indirect treatment (tx) comparison of teclistamab (tec) in MajesTEC-1 versus physician's choice of therapy in the long-term follow-up of the CASTOR, POLLUX, EQUULEUS, and APOLLO trials in patients (pts) with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Mateos, M. V.; Chari, A.; Usmani, S. Z.; Goldschmidt, H.; Weisel, K.; Qi, K. Q.; Londhe, A.; Nair, S.; Lin, X. W.; Pei, L. X.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Comparative effectiveness of teclistamab versus real-world treatments for patients with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Krishnan, A. Y.; Nooka, A. K.; Chari, A.; Garfall, A. L.; Martin, T. G.; Nair, S.; Lin, X. W.; Qi, K. Q.; Londhe, A.; Pei, L. X.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study

Meeting Abstract

Hogan, L. E.; Bhatla, T.; Teachey, D. T.; Sirvent, F. J. B.; Moppett, J.; Puyó, P. V.; Micalizzi, C.; R?Ssig, C. R.; Shukla, N.; Gilad, G.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Matching-adjusted indirect comparison (MAIC) of teclistamab (tec) versus selinexordexamethasone (sel-dex) for the treatment of patients (pts) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Bahlis, N. J.; Usmani, S. Z.; Rosiñol, L.; Krishnan, A. Y.; Nooka, A. K.; Rocafiguera, A. O.; Delforge, M.; Garfall, A. L.; van De Donk, N. W. C. J.; Rodríguez-Otero, P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

CD19-specific CAR-T cells for the treatment of CNS chloromas in children with relapsed/refractory B-cell acute lymphoblastic leukemia

Meeting Abstract

Shahid, S.; Cancio, M.; Haque, S. S.; Khakoo, Y.; McWilliams, E.; Santomasso, B. D.; Scaradavou, A.; Spitzer, B.; Wolden, S. L.; Boelens, J. J.; more...
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save